LULU vs PFE: Which Is the Better Buy?
Side-by-side comparison of Lululemon Athletica Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-21.
Lululemon Athletica Inc. · Consumer Cyclical
$98.06
+1.5% upside to fair value
Low Conviction
Grade C
VS
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LULU |
PFE |
| Current Price |
$98.06 |
$27.64 |
| Fair Value Estimate |
$99.50 |
$30.94 |
| Upside to Fair Value |
+1.5%
|
+12.0%
|
| Market Cap |
$11.1B |
$157.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
4.6x
|
17.4x
|
| Price / Sales |
1.0x
|
2.5x
|
| Price / FCF |
8.2x
|
14.3x
|
| Revenue Growth YoY |
-4.3%
|
+2.6%
|
| Gross Margin |
56.1%
|
71.3%
|
| Operating Margin |
17.8%
|
25.1%
|
| Return on Equity |
29.7%
|
4.9%
|
| Dividend Yield |
0% |
6.22% |
| FCF Yield |
12.24%
|
6.97%
|
| Analyst Consensus |
Sell
|
Hold
|
Investment Thesis
Lululemon Athletica designs and retails premium athletic apparel and accessories through company-owned stores and direct-to-consumer channels, with roughly 39,000 employees and a brand built on technical fabrics and community-led fitness positioning. The business still earns high returns on equity of 29.7% and generates $12.00 of free cash flow per share on $97.70 of revenue per share, with TTM g…
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
| Metric |
LULU |
PFE |
| Zone Low |
$74.62 |
$23.21 |
| Zone High |
$84.58 |
$26.30 |
| In Buy Zone? |
No
|
No
|